AAAAAA

   
Results: 1-14 |
Results: 14
EFFECT OF PREOPERATIVE CHEMOTHERAPY ON THE OUTCOME OF WOMEN WITH OPERABLE BREAST-CANCER
Authors: FISHER B BRYANT J WOLMARK N MAMOUNAS E BROWN A FISHER ER WICKERHAM DL BEGOVIC M DECILLIS A ROBIDOUX A MARGOLESE RG CRUZ AB HOEHN JL LEES AW DIMITROV NV BEAR HD
Citation: B. Fisher et al., EFFECT OF PREOPERATIVE CHEMOTHERAPY ON THE OUTCOME OF WOMEN WITH OPERABLE BREAST-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2672-2685
LONG-TERM TAMOXIFEN CITRATE USE AND POTENTIAL OCULAR TOXICITY
Authors: GORIN MB DAY R COSTANTINO JP FISHER B REDMOND CK WICKERHAM L GOMOLIN JES MARGOLESE RG MATHEN MK BOWMAN DM KAUFMANN D DIMITROV NV SINGERMAN LJ BORNSTEIN R WOLMARK N
Citation: Mb. Gorin et al., LONG-TERM TAMOXIFEN CITRATE USE AND POTENTIAL OCULAR TOXICITY, American journal of ophthalmology, 125(4), 1998, pp. 493-501
TAMOXIFEN AND CHEMOTHERAPY FOR LYMPH NODE-NEGATIVE, ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER
Authors: FISHER B DIGNAM J WOLMARK N DECILLIS A EMIR B WICKERHAM DL BRYANT J DIMITROV NV ABRAMSON N ATKINS JN SHIBATA H DESCHENES L MARGOLESE RG
Citation: B. Fisher et al., TAMOXIFEN AND CHEMOTHERAPY FOR LYMPH NODE-NEGATIVE, ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 89(22), 1997, pp. 1673-1682
EFFECT OF PREOPERATIVE CHEMOTHERAPY ON LOCAL-REGIONAL DISEASE IN WOMEN WITH OPERABLE BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-18
Authors: FISHER B BROWN A MAMOUNAS E WIEAND S ROBIDOUX A MARGOLESE RG CRUZ AB FISHER ER WICKERHAM DL WOLMARK N DECILLIS A HOEHN JL LEES AW DIMITROV NV
Citation: B. Fisher et al., EFFECT OF PREOPERATIVE CHEMOTHERAPY ON LOCAL-REGIONAL DISEASE IN WOMEN WITH OPERABLE BREAST-CANCER - FINDINGS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-18, Journal of clinical oncology, 15(7), 1997, pp. 2483-2493
5 VERSUS MORE THAN 5 YEARS OF TAMOXIFEN THERAPY FOR BREAST-CANCER PATIENTS WITH NEGATIVE LYMPH-NODES AND ESTROGEN RECEPTOR-POSITIVE TUMORS
Authors: FISHER B DIGNAM J BRYANT J DECILLIS A WICKERHAM DL WOLMARK N COSTANTINO J REDMOND C FISHER ER BOWMAN DM DESCHENES L DIMITROV NV MARGOLESE RG ROBIDOUX A SHIBATA H TERZ J PATERSON AHG FELDMAN MI FARRAR W EVANS J LICKLEY HL
Citation: B. Fisher et al., 5 VERSUS MORE THAN 5 YEARS OF TAMOXIFEN THERAPY FOR BREAST-CANCER PATIENTS WITH NEGATIVE LYMPH-NODES AND ESTROGEN RECEPTOR-POSITIVE TUMORS, Journal of the National Cancer Institute, 88(21), 1996, pp. 1529-1542
TAMOXIFEN AND COAGULATION
Authors: MACDONALD DM DIMITROV NV
Citation: Dm. Macdonald et Nv. Dimitrov, TAMOXIFEN AND COAGULATION, Journal of investigative medicine, 44(7), 1996, pp. 356-356
SEQUENTIAL METHOTREXATE AND FLUOROURACIL FOR THE TREATMENT OF NODE-NEGATIVE BREAST-CANCER PATIENTS WITH ESTROGEN RECEPTOR-NEGATIVE TUMORS -8-YEAR RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-13 AND FIRST REPORT OF FINDINGS FROM NSABP B-19 COMPARINGMETHOTREXATE AND FLUOROURACIL WITH CONVENTIONAL CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL
Authors: FISHER B DIGNAM J MAMOUNAS EP COSTANTINO JP WICKERHAM DL REDMOND C WOLMARK N DIMITROV NV BOWMAN DM GLASS AG ATKINS JN ABRAMSON N SUTHERLAND CM ARON BS MARGOLESE RG
Citation: B. Fisher et al., SEQUENTIAL METHOTREXATE AND FLUOROURACIL FOR THE TREATMENT OF NODE-NEGATIVE BREAST-CANCER PATIENTS WITH ESTROGEN RECEPTOR-NEGATIVE TUMORS -8-YEAR RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-13 AND FIRST REPORT OF FINDINGS FROM NSABP B-19 COMPARINGMETHOTREXATE AND FLUOROURACIL WITH CONVENTIONAL CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL, Journal of clinical oncology, 14(7), 1996, pp. 1982-1992
INVENTIONS OF AMK JSC
Authors: DIMITROV NV
Citation: Nv. Dimitrov, INVENTIONS OF AMK JSC, Metallurgist, 40(3-4), 1996, pp. 53-54
PLASMA ALPHA-TOCOPHEROL CONCENTRATIONS AFTER SUPPLEMENTATION WITH WATER-SOLUBLE AND FAT-SOLUBLE VITAMIN-E
Authors: DIMITROV NV MEYERLEECE C MCMILLAN J GILLILAND D PERLOFF M MALONE W
Citation: Nv. Dimitrov et al., PLASMA ALPHA-TOCOPHEROL CONCENTRATIONS AFTER SUPPLEMENTATION WITH WATER-SOLUBLE AND FAT-SOLUBLE VITAMIN-E, The American journal of clinical nutrition, 64(3), 1996, pp. 329-335
EFFECT OF A GARLIC EXTRACT ON PROSTAGLANDIN-E METABOLITE (PGE-M) EXCRETION
Authors: CHIOU CH BENNINK MR DIMITROV NV
Citation: Ch. Chiou et al., EFFECT OF A GARLIC EXTRACT ON PROSTAGLANDIN-E METABOLITE (PGE-M) EXCRETION, The FASEB journal, 9(4), 1995, pp. 992-992
ASCORBIC-ACID AND CELL-SURVIVAL OF ADRIAMYCIN-RESISTANT AND SENSITIVEMCF-7 BREAST-TUMOR CELLS
Authors: WELLS WW ROCQUE PA XU DP MEYER EB CHARAMELLA LJ DIMITROV NV
Citation: Ww. Wells et al., ASCORBIC-ACID AND CELL-SURVIVAL OF ADRIAMYCIN-RESISTANT AND SENSITIVEMCF-7 BREAST-TUMOR CELLS, Free radical biology & medicine, 18(4), 1995, pp. 699-708
ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14
Authors: FISHER B COSTANTINO JP REDMOND CK FISHER ER WICKERHAM DL CRONIN WM BOWMAN D COUTURE J DIMITROV NV EVANS J FARRAR W KAVANAH M LICKLEY HL MARGOLESE R PATERSON AHG ROBIDOUX A SHIBATA H TERZ J
Citation: B. Fisher et al., ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14, Journal of the National Cancer Institute, 86(7), 1994, pp. 527-537
EVALUATION OF NUCLEAR MORPHOLOGY IN ADRIAMYCIN SENSITIVE AND RESISTANT CELLS
Authors: KOMITOWSKI D CHARAMELLA LJ DIMITROV NV
Citation: D. Komitowski et al., EVALUATION OF NUCLEAR MORPHOLOGY IN ADRIAMYCIN SENSITIVE AND RESISTANT CELLS, Annals of clinical and laboratory science, 24(3), 1994, pp. 259-265
ADRENAL EFFECTS OF LOW-DOSE AMINOGLUTETHIMIDE WHEN USED ALONE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER
Authors: CARELLA MJ DIMITROV NV GOSSAIN VV SRIVASTAVA L ROVNER DR
Citation: Mj. Carella et al., ADRENAL EFFECTS OF LOW-DOSE AMINOGLUTETHIMIDE WHEN USED ALONE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER, Metabolism, clinical and experimental, 43(6), 1994, pp. 723-727
Risultati: 1-14 |